Acadia Pharmaceuticals ACAD
NASDAQ ACAD
$22.18 -3.25 (-12.78%)
At close: Sep 24, 2026 · 4:00 PM EDT

Acadia Pharmaceuticals (ACAD) EBIT (2010 - 2026)

Acadia Pharmaceuticals (ACAD) posted EBIT of $37.8 million for Q2 2026, up 919.67% on a QoQ basis from -$4.6 million in Q1 2026, and up 16.87% year-over-year from $32.4 million in Q2 2025.

Analysis

Acadia Pharmaceuticals (ACAD) EBIT (2010 - 2026) Analysis & Trends

Acadia Pharmaceuticals has reported EBIT for 17 years, with the latest figure at $37.8 million in Q2 2026.

  • On a quarterly basis, EBIT rose 16.87% year-over-year to $37.8 million in Q2 2026; TTM through Jun 2026 was $86.4 million, a 63.53% decrease from a year earlier, with the FY2025 full-year figure at $104.8 million, down 54.59% from the prior year.
  • EBIT was $37.8 million for Q2 2026 at Acadia Pharmaceuticals, up from -$4.6 million in the prior quarter.
  • The five-year high for EBIT was $153.5 million in Q4 2024, with the low at -$113.0 million in Q1 2022.
  • Average EBIT over 5 years is $4.0 million, with a median of $16.3 million recorded in 2024.
  • The sharpest annual moves came in 2024 and 2026: EBIT soared 902.21% in 2024, then slumped 123.93% in 2026.
  • Over 5 years, EBIT stood at -$46.1 million in 2022, then soared by 175.86% to $34.9 million in 2023, then surged by 339.28% to $153.5 million in 2024, then slumped by 88.67% to $17.4 million in 2025, then surged by 117.56% to $37.8 million in 2026.
  • The last three EBIT figures came in at $37.8 million (Q2 2026), -$4.6 million (Q1 2026), and $17.4 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn 7.14 Bn
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn 6.43 Bn
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -584.00 Mn
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 4.75 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn 3.16 Bn
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn 3.51 Bn
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -10.39 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn 4.27 Bn
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn 1.25 Bn
10 Acadia Pharmaceuticals 4.38 Bn 3.42 Bn 279.64 Mn 37.84 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 37.84 Mn
Mar 31, 2026 -4.62 Mn
Dec 31, 2025 17.39 Mn
Sep 30, 2025 35.76 Mn
Jun 30, 2025 32.37 Mn
Mar 31, 2025 19.29 Mn
Dec 31, 2024 153.50 Mn
Sep 30, 2024 31.64 Mn
Jun 30, 2024 30.44 Mn
Mar 31, 2024 15.21 Mn
Dec 31, 2023 34.94 Mn
Sep 30, 2023 -57.78 Mn
Jun 30, 2023 3.04 Mn
Mar 31, 2023 -53.58 Mn
Dec 31, 2022 -46.06 Mn
Sep 30, 2022 -30.87 Mn
Jun 30, 2022 -33.65 Mn
Mar 31, 2022 -113.02 Mn
Dec 31, 2021 -44.66 Mn
Sep 30, 2021 -15.30 Mn
API Access

Acadia Pharmaceuticals EBIT API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ebit&ticker=ACAD&period=max&api_key=YOUR_API_KEY